The U.S. International Trade Commission (USITC) has announced two new investigations related to China, one on revoking Permanent Normal Trade Relations (PNTR) and the other on government support for the biotech sector.

Today, China's Ministry of Commerce said that it is still weighing the implications of a U.S. Supreme Court decision striking down President Donald Trump's use of emergency powers to impose sweeping tariffs, while closely monitoring new tariff developments.

In a major development related to the Trump administration's tariff strategy, on Friday the Supreme Court held that the International Emergency Economic Powers Act (IEEPA), under which the Trump administration had justified many of its tariffs on China and other countries, does not allow the president to impose

The Trump administration has authorized Nvidia to sell its H200 AI chips to China, with a new mechanism designed to allow the government to capture a portion of the profit from the sales. However, the path forward for these exports remains precarious, facing regulatory challenges in both Beijing and Washington.

In late December, China imposed sanctions on twenty U.S. defense companies and ten executives in retaliation for a new approval by the U.S. government of arms sales to Taiwan.

The city of Wuhan and several Chinese entities have reportedly filed a $50.5 billion lawsuit in China against current and former Missouri officials in retaliation for their actions in the state lawsuit against the Chinese government and other entities over COVID-19.

In a statement to Congress made as part of a closed door session informing key Congressional committees on how the upcoming USMCA joint review will proceed, U.S. Trade Representative Jamieson Greer identified a number of areas that will affect Chinese trade and investment with the three USMCA parties.